| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $104.5M | $92.9M | $152.1M |
| YoY Revenue Growth % | +12.5% | -38.9% | — |
| Gross Profit | $91.4M | $79.5M | — |
| Gross Margin % | 87.5% | 85.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$63.9M | -$46.5M | -$114.3M |
| Operating Margin % | -61.2% | -50.1% | -75.2% |
| Net Income (GAAP) | -$70.4M | -$46.8M | -$101.4M |
| EBITDA (Normalized) | -$62.8M | -$46.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$68.9M | -$7.1M | -$71.8M |
| Capital Expenditures (CapEx) | $1.4M | $668.0K | — |
| Free Cash Flow (FCF) | -$70.3M | -$7.7M | -$71.8M |
| FCF Margin % | -67.3% | -8.3% | -47.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $194.5M | $271.9M | — |
| Total Debt (Short + Long Term) | $0 | $125.7M | — |
| Total Stockholders' Equity | $111.8M | $173.0M | — |